-
- About us
- News
- Careers
- Products & Innovations
- Ampoules
- Vials Type I
- Injectable vials
- Infusions
- Oral
- Nasal
- Healthcare
- Beauty & Care
- SGD Pharma Plus
- Media center
- Contact us
-
-
Our CSR strategy
Our company focus on ESG is fully integrated into our commercial and industrial strategies.
Welcome to SGD Pharma's Zhanjiang Plant, where safety is our top priority. We are thrilled to share our remarkable achievement of reaching 818 days without a lost time accident. Join us in celebrating our safety excellence, led by Mrs.
SGD Pharma is proud to announce the conversion of one of our two high-efficiency furnaces at our Saint-Quentin-Lamotte (SQLM) manufacturing facility in France. This conversion is part of our ambitious global decarbonisation strategy and will help reduce our overall carbon emissions by two-thirds by 2040.
SGD Pharma has proudly joined the United Nations Target Gender Equality accelerator program as a gender equality participant. This means that we are now part of a global community that makes a difference in the lives of women and girls.
SGD Pharma takes its global and local responsibilities seriously and works consistently to be compliant with all environmental, social and ethical requirements. The publication of SGD Pharma’s 2022 sustainability report reinforces our company-wide commitment to a green and sustainable present and future.
Download the full report here.
Key highlights of SGD Pharma CSR report 2022:
We are very proud of our employees at Saint-Quentin-Lamotte glass manufacturing site for their hard work in supporting our continued innovation and investment.
Thank you to the project teams for working together with group management to organize a successful internal opening of our new siliconization workshop for molded glass vials.